 12. Males must also agree to refrain from donating semen or sperm during the treatment phase and for 28 days after discontinuation from this study treatment. Male subjects enrolled in Cohort B must also agree to refrain from donating semen or sperm during the treatment phase and until 3 months after last dose of daratumumab. 